Owkin

Federated learning AI for cancer drug development and diagnostics.

Series BParis, FranceFounded 2016

About

Owkin uses AI and federated learning to analyze medical data from hospitals and research centers for cancer drug development and diagnostics. The company's technology enables training AI models on sensitive patient data without the data leaving hospital premises. Owkin partners with pharmaceutical companies and leading cancer centers to discover biomarkers and predict treatment outcomes.

Total Funding

$300M

Key Product

Owkin federated learning platform for oncology

Geography

Europe